Asterias Biotherapeutics, Inc. 4
4 · Asterias Biotherapeutics, Inc. · Filed Sep 16, 2015
Insider Transaction Report
Form 4
LEBKOWSKI JANE
Pres., Research & Development
Transactions
- Sale
Series A Common Stock
2015-09-15$6.00/sh−4,912$29,472→ 476 total
Footnotes (1)
- [F1]The shares reported herein were sold pursuant to a Rule 10b5-1 Plan adopted by the reporting person on June 30, 2015.